GlassScriptPhysician profile
Katherine Reyer
NPI 1841877636
$15,651.72
in general payments reported to CMS, 2019-2025
40 companies · $3,533 in 2025
The $3,533 reported for 2025 was more than what 97% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,587 · 2022: $3,696 · 2023: $3,427 · 2024: $3,409 · 2025: $3,533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,217.26 |
| Education | $151.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,553.65 | 2021-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $2,439.72 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Takeda Pharmaceuticals U.S.A., INC. | $1,917.21 | 2021-2025 | Glassia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $855.70 | 2021-2025 | Ofev |
| Genzyme Corporation | $787.38 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $769.48 | 2021-2025 | Dupixent |
| Grifols USA, LLC | $748.04 | 2021-2025 | Prolastin-C Liquid |
| Amgen INC. | $495.75 | 2021-2025 | Tezspire, Tavneos |
| Jazz Pharmaceuticals INC. | $492.70 | 2021-2025 | |
| Baxter Healthcare | $466.82 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Mallinckrodt Hospital Products INC. | $400.71 | 2021-2025 | Acthar |
| United Therapeutics Corporation | $348.56 | 2021-2025 | Tyvaso, Tyvaso |
| Mylan Specialty L.P. | $314.08 | 2021-2023 | Yupelri |
| Inspire Medical Systems, INC. | $304.70 | 2023-2025 | Inspire |
| Insmed, INC. | $292.56 | 2024-2025 | Arikayce, Brinsupri |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $268.78 | 2021-2024 | |
| Philips North America LLC | $264.36 | 2023-2025 | Vest Therapy Und, Image Management Subscription, (Ae4) Secretion Management |
| Bayer Healthcare Pharmaceuticals INC. | $254.31 | 2021-2024 | |
| Electromed, INC. | $233.98 | 2021-2025 | Smartvest |
| Covis Pharma Gmbh | $229.37 | 2022-2023 | |
| Harmony Biosciences LLC | $125.19 | 2023-2025 | Wakix |
| Genentech USA, INC. | $117.48 | 2021-2023 | Xolair |
| Axsome Therapeutics, INC. | $111.98 | 2023-2025 | Sunosi |
| Verona Pharma, INC. | $97.47 | 2025 | Ohtuvayre |
| Avadel Cns Pharmaceuticals, LLC | $97.15 | 2024-2025 | Lumryz |
| Phadia US INC. | $83.32 | 2023-2025 | Immunocap |
| Teva Pharmaceuticals USA, INC. | $75.04 | 2022 | |
| Shield Therapeutics INC | $74.71 | 2023-2025 | Accrufer |
| Inogen, INC. | $73.05 | 2022 | |
| Eisai INC. | $62.41 | 2021 | |
| Avanir Pharmaceuticals, INC. | $62.27 | 2022 | |
| Merck Sharp & Dohme LLC | $45.00 | 2022-2023 | |
| Advanced Respiratory, INC | $40.40 | 2021 | |
| Azurity Pharmaceuticals, INC. | $38.83 | 2023-2025 | Edarbi, Horizant |
| Pfizer INC. | $23.00 | 2024 | |
| Hikma Pharmaceuticals USA | $20.20 | 2024 | Ryaltris |
| Resmed Corp | $18.27 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $17.62 | 2023 | Opsumit |
| Lilly USA, LLC | $17.30 | 2025 | Zepbound |
| Paratek Pharmaceuticals, INC. | $13.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Reyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.